Thailand Medical Device Registration

Thailand is one of Southeast Asia’s most dynamic medical device markets, offering strong growth potential and increasing demand for healthcare innovation. For foreign manufacturers aiming to enter this strategic market, navigating the evolving Thailand medical device regulations governed by the Thai Food and Drug Administration (Thai FDA) under the Ministry of Public Health, MoPH, is essential for successful market access.

Cisema supports your full journey toward Thailand medical device registration, including early stage planning, risk classification and feasibility assessments, documentation readiness, regulatory strategy, and quality control inspections. Although Cisema does not currently act as a license holder in Thailand, we support your pre-registration planning to ensure a smooth transition when a locally authorized entity is appointed.

Whether you are targeting future registration in Thailand of Class 1, 2, 3, or 4 medical devices or in vitro diagnostics, planning an ASEAN-wide rollout, or simply evaluating your readiness for Thai FDA engagement, Cisema helps streamline your entry with compliant strategies, ASEAN harmonization guidance, and early regulatory intelligence.

Thailand Medical Device Registration
Registration of medical devices in Thailand

Our Services for IVD Medical Device Market Registration in Thailand

Cisema provides expert regulatory consulting and pre-registration support tailored to Thai FDA expectations and ASEAN frameworks throughout the IVD and medical device registration process.

Regulatory Strategy & Classification

Confirm product status as an IVD or medical device in Thailand under Thai FDA guidelines
Determine risk class, Class 1 to 4, and assess grouping logic
Advise on appropriate registration route: notification, listing, or full registration
Estimate review time and scope based on classification and novelty
Align your strategy with the Medical Device Act and ASEAN harmonization

Documentation Readiness & Feasibility Analysis

Evaluate documentation against ASEAN CSDT and Thai formatting rules
Identify gaps, inconsistencies, and translation needs
Score technical readiness and highlight priority remediation areas
Advise on IFU, labeling, and claims aligned with intended use and local standards
Provide tailored roadmaps for dossier preparation and submission planning

Regulatory Intelligence & Local Adaptation

Monitor Thai FDA announcements, procedural updates, and ministerial regulations
Interpret and translate regulatory changes for global teams
Map license holder, importer, and distributor roles based on the Medical Device Control Division structure
Track enforcement trends, including new regulations, affecting market readiness
Clarify deviations between ASEAN CSDT and Thailand’s medical device framework

Strategic ASEAN Integration

Support ASEAN regional planning while aligning with Thailand medical device requirements
Coordinate simultaneous rollouts in Singapore, Malaysia, Vietnam, Indonesia, and the Philippines
Advise on bundling strategy for multiple classes and devices
Facilitate risk-based submission strategies and mitigation planning.

Quality Control Inspection Services for Medical Devices & IVDs in Thailand

Cisema’s quality control inspection services support your Thai medical device & IVD operations by verifying compliance with the Thai FDA and global quality expectations. We ensure readiness for local distribution, regional supply, or internal audits:

Incoming Goods Inspections

Verify product identity, packaging, and required shipping documents
Ensure label accuracy and regulatory compliance with Thai IVD and medical device regulations

In Process Monitoring

Conduct audits of Thai-based repackaging or assembly processes
Evaluate SOP implementation and traceability for high risk devices

Final Product Inspection

Perform functional checks, Acceptance Quality Limit, sampling, and final product release approval
Validate IFUs and labeling for conformity with Thai public health expectations

Custom Audits

Audit preparation support for Thai FDA site visits, ISO 13485, or Therapeutic Goods Administration, TGA, or MDSAP readiness
Inspect quarantined, returned, or refurbished products for regulatory compliance
Advise on bundling strategy for multiple classes and devices
Confirm serial numbers and document verification for authorization.

Why Work with Cisema?

Local expertise with global reach

Our bilingual teams bridge international quality standards with local regulations

Proven track record

Over 20 years supporting market approvals and compliance in China and Asia Pacific

End-to-end solutions

From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle

Industry breadth

Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Role of a China Agent

Useful Articles

View More

What Are the Medical Device Renewal Timelines Across ASEAN?

Learn about license validity and renewal rules for medical devices in Southeast Asia.

July 9, 2026
What Are the Medical Device Renewal Timelines Across ASEAN?

How to Fast-Track Medical Device Registration in Southeast Asia

Explore fast-track medical device registration in Southeast Asia, cut timelines by 6–12 months, and accelerate market entry with Cisema.

July 9, 2026
How to Fast-Track Medical Device Registration in Southeast Asia

Breaking Into Southeast Asia’s Dental Market: 3 Things Manufacturers Need to Get Right

Enter Southeast Asia’s dental market with a clear strategy: navigate regulatory complexity, sequence market entry, and retain control of registrations to scale efficiently.

May 6, 2026
Breaking Into Southeast Asia’s Dental Market: 3 Things Manufacturers Need to Get Right
Malaysian dentist with a patient in a well lit dental clinic.

Cisema Launches a Redesigned Website

Learn about Cisema’s redesigned website with faster performance, clearer navigation and expanded Asia Pacific coverage.

May 6, 2026
Cisema Launches a Redesigned Website
Cisema Logo: Navigating Regulation, Empowering Innovation
Previous
Previous

Other Markets We Support for Medical Device & IVD Registration

In addition to Thailand, Cisema supports IVD and device registration, regulatory representation, and quality inspection services in:

China

Hong Kong SAR

Singapore

Malaysia

Taiwan

Philippines

Indonesia

South Korea

Vietnam

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

Previous
Previous

Latest Insights

View More

Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

Circular No. 2/2026 revises prohibited, restricted, colorant, and preservative requirements for cosmetics marketed in Malaysia.

August 20, 2026
Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?

Brands must audit ingredients, suppliers and packaging before January 2028 to ensure compliance with GB 7916-2026.

August 18, 2026
China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?
Scientist in clean modern room inspects cosmetics.

China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Companies can benefit from expanded toxicology data exemptions, simplified cosmetics registration procedures, and more efficient compliance pathways

August 18, 2026
China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories

August 18, 2026
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed

New NCI rules reduce administrative burden, streamline dossiers, and expand opportunities to reuse existing safety data.

August 18, 2026
China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed
This stock photo features a close-up, high-angle shot focusing on a skincare product arrangement set against a light-colored, wood-grain surface.

NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria

Review China's new draft standards for cosmetic cheilitis and contact urticaria before the August 15, 2026, consultation deadline.

August 18, 2026
NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria
Previous
Previous

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device or IVD in Thailand.

Request Proposal